Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Seattle, USA
1191 Second Avenue
Suite 1105
Seattle, WA, 98101
USA

People

CEO & Board Member
VP, Research
VP, Business Development & Alliance Management
VP, Regulatory Affairs
VP, Finance
Board Director
Board Director
Board Director
Show All People

Funding

TOTAL $86.6M
FUNDING TOTAL $86.6M
Series A, 1/2010
MedImmune Ventures
ARCH Venture Partners
Domain Associates
Frazier Healthcare Ventures
$51.6M
Venture Round, 10/2012
Celgene
$35M

Tags

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of novel toll-like receptor 8 therapeutics for the treatment of cancer, respiratory, allergy, and autoimmune/inflammatory diseases. The company was founded in 2006 and is headquartered in San Diego, California with additional operations in Seattle.

Recent Milestones

Videos

Screenshots

VentiRx Pharmaceuticals screenshot
Above: Home Page
Uploaded: 1/13/10

Sources

  1. VentiRx Pharma Extends Series A To $51.6M (fis.dowjones.com) [edit]
  2. VentiRx Secures $35M from Celgene; VCs Get Possible Path to Liquidity (pevc.dowjones.com) [edit]
Edit This Page
Last Edited 2/24/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy